Trademark: 87791663
Word
ACUITY PHARMACEUTICALS
Status Date
Monday, January 14, 2019
Filing Date
Friday, February 9, 2018
Published for Opposition
Tuesday, April 17, 2018
Abandoned Date
Monday, January 14, 2019
5 House mark used for drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of diseases and conditions, including ocular diseases, namely, uveitis, retinal vein occlusion, macular edema, macular disease, retinal disease, and glaucoma and diseases and conditions in joints, namely, osteoarthritis, bursitis, fibrotic diseases, and infections
10 House mark for sustained drug delivery systems for pharmaceuticals
Jan 14, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 14, 2019
Abandonment - No Use Statement Filed
Jun 12, 2018
Noa E-Mailed - Sou Required From Applicant
Apr 18, 2018
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 18, 2018
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 18, 2018
Automatic Update Of Assignment Of Ownership
Apr 17, 2018
Official Gazette Publication Confirmation E-Mailed
Apr 17, 2018
Published For Opposition
Mar 28, 2018
Notification Of Notice Of Publication E-Mailed
Mar 8, 2018
Assigned To Lie
Feb 28, 2018
Approved For Pub - Principal Register
Feb 28, 2018
Examiner's Amendment Entered
Feb 28, 2018
Notification Of Examiners Amendment E-Mailed
Feb 28, 2018
Examiners Amendment E-Mailed
Feb 28, 2018
Examiners Amendment -Written
Feb 28, 2018
Notification Of Non-Final Action E-Mailed
Feb 28, 2018
Non-Final Action E-Mailed
Feb 28, 2018
Non-Final Action Written
Feb 27, 2018
Previous Allowance Count Withdrawn
Feb 27, 2018
Approved For Pub - Principal Register
Feb 27, 2018
Assigned To Examiner
Feb 16, 2018
New Application Office Supplied Data Entered In Tram
Feb 13, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
